| 103573-2 | FDA package insert Cosmetic facility registration | DOCUMENT.REGULATORY |
| 103574-0 | Dog dander IgE panel - Serum or Plasma | PANEL.ALLERGY |
| 103575-7 | Cat epithelium IgE panel - Serum or Plasma | PANEL.ALLERGY |
| 103576-5 | Horse dander IgE panel - Serum or Plasma | PANEL.ALLERGY |
| 103577-3 | Albumin (immunoassay) | CHEM |
| 10358-0 | Teichoate Ab (immune diffusion (id)) | MICRO |
| 103588-0 | Etizolam in Cord tissue (qualitative, confirmatory method) | DRUG/TOX |
| 103589-8 | Flualprazolam in Cord tissue (qualitative, confirmatory method) | DRUG/TOX |
| 10359-8 | Asialoganglioside GM1 IgM Ab | SERO |
| 103590-6 | Bacterial vaginosis RNA in Vagina (qualitative, probe with amplification) | MICRO |
| 103591-4 | Comprehensive foot screening report Document | DOC.MISC |
| 103592-2 | Retinal eye screening report Document | DOC.MISC |
| 103593-0 | Cell growth of Amniocytes Qualitative (qualitative, tissue culture) | SPEC |
| 103594-8 | Acetyl norfentanyl in Cord tissue (confirmatory method) | DRUG/TOX |
| 103595-5 | Certificate of Medical Necessity | ATTACH |
| 103596-3 | Durable medical equipment proof of delivery receipt | ATTACH |
| 103597-1 | Pain management form or template | ATTACH |
| 103598-9 | Direct antiglobulin test.polyspecific reagent on Red Blood Cells from Fetus (qualitative) | BLDBK |
| 103599-7 | Reason for discharge from the intensive care unit | ADMIN.PATIENT |
| 1036-3 | G Ab from Blood product unit (qualitative) | BLDBK |
| 10360-6 | DNA single strand IgG Ab | SERO |
| 103600-3 | Baclofen (Urine, lc/ms/ms) | DRUG/TOX |
| 103601-1 | Staphylococcus aureus MLVA type in Isolate or Specimen (molecular genetics method) | MICRO |
| 103602-9 | 6-Hydroxychlorzoxazone (Urine) | DRUG/TOX |
| 103603-7 | Tick-borne Ab panel - Serum | PANEL.MICRO |
| 103604-5 | Carbamazepine 10,11-Epoxide (Urine) | DRUG/TOX |
| 103605-2 | Paroxetine metabolite I (Urine, confirmatory method) | DRUG/TOX |
| 103606-0 | Paroxetine M-II (Urine, confirmatory method) | DRUG/TOX |
| 103607-8 | Paroxetine metabolite III (Urine, confirmatory method) | DRUG/TOX |
| 103608-6 | Sulbactam+Durlobactam (gradient strip) | ABXBACT |
| 103609-4 | Imatinib (lc/ms/ms --24 hours post dose) | DRUG/TOX |
| 10361-4 | DNA single strand IgM Ab | SERO |
| 103610-2 | Pazopanib (lc/ms/ms --24 hours post dose) | DRUG/TOX |
| 103611-0 | Sunitinib (lc/ms/ms --24 hours post dose) | DRUG/TOX |
| 103612-8 | N-Desethyl Sunitinib (lc/ms/ms --24 hours post dose) | DRUG/TOX |
| 103613-6 | Sunitinib total (lc/ms/ms --24 hours post dose) | DRUG/TOX |
| 103614-4 | Gefitinib (lc/ms/ms --24 hours post dose) | DRUG/TOX |
| 103615-1 | Erlotinib (lc/ms/ms --24 hours post dose) | DRUG/TOX |
| 103616-9 | Creatinine (lc/ms/ms) | CHEM |
| 103617-7 | Helicobacter pylori IgG Ab (Blood, qualitative, immunoassay) | MICRO |
| 103618-5 | Hepatitis B virus RNA (viral load) (naa with probe detection) | MICRO |
| 103619-3 | Coagulation surface induced.lupus sensitive.buffer (LA control) in Platelet poor plasma (coagulation assay) | COAG |
| 10362-2 | Endomysium IgA Ab (qualitative) | SERO |
| 103620-1 | Lupus anticoagulant aPTT screening panel - Platelet poor plasma (coagulation assay) | PANEL.COAG |
| 103621-9 | Small lymphocytic lymphoma chromosome deletions AndOr rearrangements or Tissue (Blood, fish) | MOLPATH.REARRANGE |
| 103622-7 | Enterobacter spp DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 103623-5 | Enterococcus faecalis+Enterococcus faecium DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 103624-3 | Klebsiella pneumoniae and Klebsiella oxytoca DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 103625-0 | Mycobacterium marinum DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 103626-8 | Mycobacterium ulcerans DNA in Specimen (qualitative, naa with probe detection) | MICRO |